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Donald T. Donovan,* Bobby R. Alford,* James F. Hejtmancik,* Vittorio Colantuoni,*
Loredana Quadro,* Edward Limbert,!! Irene Halperin,§ Enric Vilardell,§ and
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The hereditary conditions ofprimary cutaneous lichen amyloidosis and multiple endocrine neoplasia
type 2 (MEN 2] are rare clinical entities. The initial reports of two families in which the h\'0 conditions
coincided have led to the identification of at least eight additional families with this clinical
syndrome. In this report we describe the clinical features in five of these eight families. The salient
feature in these five families is the presence of unilateral (46%) or bilateral (64%) pruritic and
lichenoid skin lesions located over the upper portion ofthe back. Family members describe these skin
lesions as intermittently intensely pruritic leading to scratching and excoriation of the upper back
region. The presence of MEN 2 has been documented in 97% of family members with this skin lesion,
the one exception being a child who is at risk for development of MEN 2A in whom the diagnosis has
not yet been made. Of family members who have MEN 2A,27% do not have an identifiable skin lesion,
although the skin lesion developed in one patient two years after a curative thyroidectomy for
medullaiy thyroid carcinoma (MTC). Four of the five families have members with pheochromocytoma; one with five affected members has only MTC. The finding of this clinical syndrome in
geographically diverse portions ofthe world and the lack of overlap with MEN 2 A without the skin
lesion suggest it is a distinct clinical variant ofMEN2A. (Henry Ford Ho.sp MedJ 1992;40:249-52)

T

he association of multiple endocrine neoplasia type 2A
(MEN 2A) and hereditary localized pruritus was first observed in an Italian family (1). In a parallel series of observations, a Texas family was observed to have the same type of pruritus and histological examination demonstrated the presence of
cutaneous lichen amyloid (CLA) characteristic of that found in
classical cases of primary CLA (2). A more detailed evaluation
in the Italian family subsequently confirmed the finding of amyloid (3), although the observation was made that family members may not have amyloid deposition early in the evolution of
the skin lesion.
These initial reports were followed by reports of three additional families with this characteristic skin lesion in association
with MEN 2A (4-6) from Spain, France, and the United States.
In each of these families the skin lesion was found in the characteristic location on the upper back. In none of these family members was the skin lesion found in individuals who were not gene
carriers or at risk for MEN 2A.
Of particular interest is the report of a French family (5,7)
which noted the dermatome-specific localization ofthe skin lesion and postulated a neurologic condition affecting these dermatomes as the primary cau.se of the lesion. They cited the clinical syndroine "notalgia paresthetica," a localized pruritic lesion
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seen at the tip of the scapula and associated with characteristic
EMG abnormalities in the affected dermatomes (8), as a model
for how a neurologic abnormality might cause the formation of
the skin lesion and amyloid. Unfortunately, they were unable to
find any evidence of neurologic deficit in their family members.
This report describes the clinical features of five families with
this clinical syndrome, two of whom are previously unreported.

Materials and Methods
Three of the five families have been the subjects of previous
reports (2,4,9). There were a total of 44 affected patients of
whom 31 exhibited both MEN 2A and either the cutaneous lesion or intermittent pruritus. One patient, a young child, maniSubmltled for publication: December 4, 1991,
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Table 2
Incidence of CLA in Five Families

Table 1
Incidence of MEN 2A in Five Families
Family
1
2
3
4
5
Total

Females
6
7
6
5
3
27

Males

F+ M

Family

Females

Males

9
1
3
2
2
17

15
8
9
7
5
44

1
2
3
4
5
Total

7
4
4

(I

No significant sex difference was observed for the occurrence of MEN 2A (x^ = 2.22,
P>0.15).

2
2
19

2
3
(I
1.1

F4-M
15
4
6
5
2
32

No significant difference was observed for the occurrence of CLA (x* = 0.78, P > 0.30).

on histologic findings of medullary thyroid carcinoma (MTC)
or abnormal levels of calcitonin (CT) for either basal .semm levels and/or upon stimuladon of the pafient with pentagastrin (0.5
p,g/kg) as previously described (10).
Nonparametric statistical analysis was performed using Statworks on an Apple Macintosh computer.

Results
Tables 1 and 2 show the respective incidences of MEN 2A
and CLA in the five families. In both cases, chi-square analysis
did not show significant differences in disease occurrence between males and females. As demonstrated (Fig 1), most patients (31 of 44) manifested both MEN 2A and CLA; some had
only MEN 2A (12 of 44); one, achild, had CLA alone. The location of the skin lesions (Fig 2) was either predominantly unilateral from the right side to the midline (10 of 26) or bilateral extending across the midline (14 of 26). Of note, in the one famdy
Fig I—Pie chart showing the percentage of incidences of MEN
documented to be affected with only MTC, the cutaneous le2A and CLA (.shaded area), MEN 2A alone (black area), and
sions were multifocal.
CLA alone (white area) in 44 affected patients.
The age of onset of CLA (Fig 3) occurred mainly before the
age of 20 years with the median age of onset being 13 years
(range 3 to 26 years; n = 26). The median age for diagnosis of
MEN 2A in those patients with both diseases was 29 years
ACROSS
RIGHT SIDE TO
LEFT SIDE TO
MULTIFOCAL
DESCRIPTION
MIDLINE
MIDLINE
HIDLINE
(range 8 to 80 years; n = 26).
With the exception of one family member, 30 of 31 patients
with both MEN 2A and CLA presented with symptoms of CLA
prior to the diagnosis of MEN 2A. This one patient developed
the skin lesion after curative treatment for MTC. She was found
to have an abnormal pentagastrin test (basal CT 28 pg/mL;
ITOHBER
postpentagastrin 2,486 pg/mL) on her initial screening at age 26
10
11
(N > 261
but had no detectable skin lesion. The diagnosis of MEN 2A was
confirmed by the finding of MTC in both lobes of her thyroid.
Fig 2—A diagrammatic representation demonstrating the lo- Postoperarive and two-year pentagastrin test results showed a
basal CT value of 7 pg/mL with no increase after pentagastrin.
calization ofthe skin lesion in 26 patients. The asterisk (*) denotes that the three patients who presented with multifocal le- On her two-year follow-up visit, a left-sided pruritic skin lesion,
sions were all members ofthe same pedigree which also was the consistent with eariy CLA, was noted for the first time. Tests for
pheochromocytoma, including magnetic resonance imaging °
one family who only manifested MTC.
the adrenal glands, were negative.
As shown in the plot of age versus area of skin lesion (Fig h
there
was a weak coefficient of determination (R- = 0.24) m
fested only CLA. Updated information on the size and location
eating
a tendency for larger lesions to be associated ^ i * '^"^
of the skin lesion(s) was obtained for 26 of 32 pafients. The
creasing
age. Of a total of 26 lesions analyzed (10 in males; ^
missing subjects were either long deceased (n = 4) or unwilling
females),
the three largest lesions of 200, 180, and BOcm^^e
to attend follow-up (n = 2). The diagnosis of MEN 2 A was based

W
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Fig 3—Histograms showing the relative ages at onset for either MEN 2 A or CLA in 26 affected patients.
actually observed in females aged 65, 25, and 35 years, respectively. However, all the other lesions were less than 100 cmwith a median area of 50 cm- (range 6 to 100 cm-) for a median
age of 33 years (range 8 to 80 years).
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y = 17.577 + 1.4131Z

R A 2 = 0.240
•

Discussion
The results from this study demonstrate that in five families
there is a variant of the classic MEN 2A syndrome in that 31
(71 %) of 44 affected members presented with both MEN 2A and
pruritic lichenoid skin lesion localized over the upper back from
dermatomes C4 to T6. The cutaneous skin lesion, which shows
autosomal dominant inheritance, appears to evolve over a period of years from an area of pruritis, usually first noticed in
childhood, to form a dark protmding interscapular lesion in
adulthood that endures throughout the patient's lifetime. Biopsy
specimens taken from more advanced stages of the skin lesions
have been found to be positive for amyloid with Congo Red
staining (2-4) leading to the classification of this syndrome as
primary CLA (2). With the exception of the CLA-like skin lesions, these patients appear to follow a clinical course similar to
classical MEN 2A patients, or, in the case of one of the pedigrees
(4), to classical hereditary MTC. To our knowledge, there are no
common ancestors between the five families.
Classical primary CLA, exhibiting autosomal dominant inheritance of variable penetrance for the rare familial form of the
disorder, has been thoroughly reviewed in a recent symposium
on the subject (11). The salient clinical, epidemiological, and
biochemical features of this syndrome may be briefly summarized. Patients present with persistent pruritic lesions which are
discrete, firm, hyperkeratotic papules which can be brown in
color. These early macular lesions, which tend later to become
lichenoid, are most often observed in the lower extremities and
less frequently on the upper back (11). The CLA tends to occur
in middle-age, with a peak incidence between 30 and 50 years,
and usually follows a chronic course although it can be of short
duration. Classical primary CLA is regarded as a rare clinical
entity in Europe but is fairly common in Southeast Asia and
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F'lg 4—A plot of the age of the patients versus the size of their
skin lesion (n = 26). Linear regression analysis yielded a coefficient of determination R- = 0.24.

some South American countries and is observed more often in
females (12). It is not clear, however, whether this unequal gender distribution is also observed for the hereditary form of the
syndrome. In the South American cases, about one-third have a
family history of the disorder (13). The amyloid deposits occur
in the dermal papillae, and biochemical analysis of the amyloid
has shown that molecular species of keratin probably result
from degenerated epidermal cells (14). The etiology of this syndrome remains unknown although chronic irritation has been
suggested as a cause for CLA termed "friction amyloidosis"
(L5).
In contrast, the affected patients we observed in the five pedigrees had a much earlier onset of CLA, usually in childhood,
and with an apparentiy equal gender distribution. Also, the lesions are confined to the interscapular region of the back. As in
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classical primary CLA, however, for both nonfamilial and familial forms, the amyloid, when detected, is found in the papillary layer of the dermis and stains positive for kerafin (2-4).
The form of CLA which we have described may be related to
notalgia paresthetica (5,7) which is an inherited sensory neuropathy of the posterior rami of the dorsal nerves from T2 to T6
(8,16). However, further research is needed to better delineate
and characterize the skin lesion and the possible relationship to
either an underlying neurosensory or neuromuscular disorder.
Nonetheless, it is reasonable to postulate that the cause of the familial CLA we have described probably arises from the intense
localized intermittent pmritus leading to repeated scratching.
The effect of such constant irritation, in tum, could thus be construed as "friction amyloidosis" manifesting at first as macular
amyloidosis and progressing over time to the lichenoid form.
Proof of this hypothesis awaits the demonstration of an inherited
neurologic abnormality.
In most pafients, with the excepfion of one, the diagnosis of
CLA has preceded the diagnosis of MEN 2A. In one patient we
observed the development of a skin lesion consistent with CLA
after curative treatment for MTC and she has no evidence of
pheochromocytoma. Therefore, it seems unlikely that a tumor
product derived from MTC caused the development of the skin
lesion in this patient. In several other patients there has been
continued pruritus and no regression of the skin lesion despite
curative thyroidectomy for MTC.
In conclusion, we have characterized a distinct variant ofthe
MEN 2A syndrome and have summarized our findings in five of
eight families who appear to manifest both MEN 2A and CLA.
It appears that greater than 5% of reported family pedigrees affected with MEN 2A exhibit this variant form of the syndrome.
Perhaps the most interesting feature of this syndrome is the possibdity that isolafion and cloning ofthe gene for MEN 2 on chromosome 10, likely to be a unique cancer gene, may lead to insight with regard to the causative mechanism for certain forms
of cutaneous lichen amyloidosis, a much more common disorder.
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